Join us on Wednesday, September 8 at 14:30 for the formal recognition of all IMS award recipients in the Plenary Session Hall, Hall A.
S. Vincent Rajkumar, MD
Rochester, United States
The Waldenström Award has been given by the IMS at each International Myeloma Workshop since 1989. This award is given to outstanding researchers in recognition of their contributions to the myeloma field. The award is named for Professor Jan Waldenström, who was a pioneer in treating blood cancer
Saad Usmani, MD
Levine Cancer Institute/Carolinas Healthcare System
Charlotte, United States
In recognition to the outstanding research developed by Dr. Bart Barlogie in the field of multiple myeloma, the IMS established the Bart Barlogie Young Investigator Award. The Bart Barlogie Young Investigator Award is given to an investigator under the age of 45 years to both recognize and stimulate excellence in myeloma research.
E. Paola Neri, PhD, MD
University of Calgary, Arnie Charbonneau Cancer Institute
Established by the IMS to honor the seminal contributions of Dr. Ken Anderson from bench to bedside translational research, the Ken Anderson Young Investigator Award is given to an investigator under the age of 45 to both recognize and stimulate excellence in myeloma research.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.